<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1"/><link rel="stylesheet" href="https://static.semafor.com/_next/static/css/5e0bc50507719ef8.css" data-precedence="next"/><link rel="stylesheet" href="https://static.semafor.com/_next/static/css/6f8c5c77224cbaea.css" data-precedence="next"/><link rel="stylesheet" href="https://static.semafor.com/_next/static/css/0f210b31207e2542.css" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" href="https://static.semafor.com/_next/static/chunks/webpack-d1bfd1d798fde2bf.js"/><script src="https://static.semafor.com/_next/static/chunks/fd9d1056-712a0b1629fd2408.js" async=""></script><script src="https://static.semafor.com/_next/static/chunks/938-d3b4064a808f12ed.js" async=""></script><script src="https://static.semafor.com/_next/static/chunks/main-app-d6e83bdf3cfbc71f.js" async=""></script><script src="https://static.semafor.com/_next/static/chunks/907-8c629f6d0cffc20a.js" async=""></script><script src="https://static.semafor.com/_next/static/chunks/462-25b4f5a6f256df73.js" async=""></script><script src="https://static.semafor.com/_next/static/chunks/app/layout-72863275accc636e.js" async=""></script><script src="https://static.semafor.com/_next/static/chunks/626-bdaa8c7a3f769519.js" async=""></script><script src="https://static.semafor.com/_next/static/chunks/896-ca0468535763e9e5.js" async=""></script><script src="https://static.semafor.com/_next/static/chunks/app/article/%5B...slug%5D/page-13b775446028798a.js" async=""></script><script src="https://static.semafor.com/_next/static/chunks/app/error-1777214bcca54bb2.js" async=""></script><link rel="manifest" href="/site.webmanifest" crossorigin="use-credentials"/><link rel="canonical" href="https://www.semafor.com/article/05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines"/><title>South Africaâs Afrigen targets local diseases with mRNA vaccines | Semafor</title><meta name="description" content="South African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist&#x27;s team to develop gene therapy treatments that target diseases that plague Africa. "/><meta name="robots" content="max-image-preview:large"/><meta name="article:published_time" content="2024-05-23T13:37:01+00:00"/><meta name="article:modified_time" content="2024-05-23T14:37:01+01:00"/><meta name="article:section" content="africa"/><meta name="article:author" content="https://www.semafor.com/author/alexis-akwagyiram"/><meta property="og:title" content="South Africaâs Afrigen targets local diseases with mRNA vaccines | Semafor"/><meta property="og:description" content="South African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist&#x27;s team to develop gene therapy treatments that target diseases that plague Africa. "/><meta property="og:url" content="https://www.semafor.com/article/05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines"/><meta property="og:image" content="https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=0,125,1600,840&amp;w=1200&amp;h=630&amp;q=75&amp;auto=format"/><meta property="og:image:height" content="1200"/><meta property="og:image:width" content="630"/><meta property="og:type" content="article"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:title" content="South Africaâs Afrigen targets local diseases with mRNA vaccines"/><meta name="twitter:description" content="South African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist&#x27;s team to develop gene therapy treatments that target diseases that plague Africa. "/><meta name="twitter:image" content="https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=0,125,1600,840&amp;w=1200&amp;h=630&amp;q=75&amp;auto=format"/><link rel="apple-touch-icon" href="/apple-touch-icon.png" sizes="180x180"/><link rel="icon" href="/favicon-32x32.png" type="image/png" sizes="32x32"/><link rel="icon" href="/favicon-16x16.png" type="image/png" sizes="16x16"/><link rel="mask-icon" href="/safari-pinned-tab-icon.svg" type="image/png" sizes="16x16" color="#000000"/><script src="https://static.semafor.com/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js" noModule=""></script></head><body style="overflow-x:hidden"><script type="application/ld+json">{"@context":"https://schema.org","@type":"NewsArticle","headline":"South Africaâs Afrigen targets local diseases with mRNA vaccines | Semafor","url":"https://www.semafor.com/article/05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines","thumbnailUrl":"https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=256,0,1089,1089&w=800&h=800&q=75&auto=format","image":["https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=256,0,1089,1089&w=600&h=600&q=75&auto=format","https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=74,0,1452,1089&w=800&h=600&q=75&auto=format","https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=0,95,1600,900&w=800&h=450&q=75&auto=format"],"datePublished":"2024-05-23T10:16:24Z","dateModified":"2024-05-23T14:37:01+01:00","articleSection":"africa","creator":["Alexis Akwagyiram"],"author":[{"@type":"Person","name":"Alexis Akwagyiram","url":"https://www.semafor.com/author/alexis-akwagyiram"}]}</script><script id="breadcrumbs" type="application/ld+json">{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@context":"http://schema.org","@type":"ListItem","name":"Africa","position":1,"item":"https://www.semafor.com/vertical/africa"}]}</script><div data-testid="ad-sticky-header" class="styles_adHeaderMargin__rnWaD"><div class="styles_adContainer__X2SPy styles_adHeaderContainer__toh7C"><div class="styles_innerAdContainer__InIPz"><div id="ad-header" class="styles_ad__ECTuS" data-testid="ad" data-ad-density="true"></div></div></div></div><div class="styles_container__dNZq9"><div class="styles_headerWrapper__LMmll"><header class="styles_header__0cb1p"><div class="styles_mobileDateNav__qj7aq"><div class="styles_mobileDateRow__V9eOU"><div class="styles_dates__7Altw"><div class="styles_timeWrapper__xYsnW"><img data-testid="rotating-globe" alt="rotating globe" loading="lazy" width="12" height="12" decoding="async" data-nimg="1" class="styles_earthIcon___5xDc" style="color:transparent" src="https://static.semafor.com/_next/static/media/spinning-earth.eafcef04.gif"/><div></div></div><div></div></div><span class="styles_linkWrapper__cekBV"></span></div><div class="styles_mobileDateRow__V9eOU"><div class="styles_mobileLinks__ZCled"><a href="/events" class="styles_navItem__iaHj4">Events</a><a href="/newsletters" class="styles_navItem__iaHj4">Newsletters</a></div><nav class="styles_nav__tGFtt"><div class="styles_drawer__4P0Og styles_button__NsBiE"><button><img alt="Open navigation" loading="lazy" width="44" height="34" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/nav-open.bd13f47f.svg"/></button><button class="styles_mobileClose__CQma6 styles_closed__Z1AEK"><img alt="Close navigation" loading="lazy" width="44" height="34" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/nav-close.69baa99c.svg"/></button></div><div data-testid="flyin-container" class="styles_drawer__4P0Og styles_flyin__NChBU styles_closed__Z1AEK"><div data-testid="flyin-overlay" class="styles_overlay__1DZXc styles_closed__Z1AEK"><button class="styles_closeButton__p1R8q"><img alt="Close navigation" loading="lazy" width="44" height="34" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/nav-close.69baa99c.svg"/></button><div class="styles_menu__L2d8x styles_flyinMenu__ooq1p"><div class="container"><ul class="verticals"><li><a rel="noreferrer" href="/"><span class="">Home</span></a></li><li><a rel="noreferrer" href="/vertical/politics"><span class="">politics</span></a></li><li><a rel="noreferrer" href="/vertical/business"><span class="">business</span></a></li><li><a rel="noreferrer" href="/vertical/tech"><span class="">technology</span></a></li><li><a rel="noreferrer" href="/vertical/netzero"><span class="">net zero</span></a></li><li><a rel="noreferrer" href="/vertical/africa"><span class="">africa</span></a></li><li><a rel="noreferrer" href="/vertical/security"><span class="">security</span></a></li><li><a rel="noreferrer" href="/vertical/media"><span class="">media</span></a></li><li><a rel="noreferrer" href="/hub/global-elections"><span class="long-title">Global Elections</span></a></li></ul><ul class="pages"><li><ul><li><a target="_blank" rel="noreferrer" href="/events">Events</a></li><li><a target="_blank" rel="noreferrer" href="/newsletters">Newsletters</a></li><li><a target="_blank" rel="noreferrer" href="/hub/mixed-signals-media-podcast">Podcast</a></li></ul></li><li><ul><li><a href="/about">About</a></li><li><a href="https://semafor.com/speakers-bureau">Speakers Bureau</a></li><li><a href="/careers">Careers</a></li></ul></li><li><a href="/privacy">Privacy</a><div class="styles_copy__VZgiA">Â© <!-- -->2024<!-- --> Semafor Inc.</div></li></ul><a class="nav-logo" href="/"><img alt="Semafor Navigation Logo" loading="lazy" width="230" height="44" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/semafor-logo-long.d14b90e5.svg"/></a></div></div></div><div role="none" class="styles_overlayContainer__N8gtd styles_closed__Z1AEK"></div></div></nav></div></div><div data-testid="mobile-drawer" class="styles_drawer__4P0Og styles_mobileNav__9_m9D styles_closed__Z1AEK"><div class="styles_menu__L2d8x styles_mobileMenu__rBl2u"><div class="container"><ul class="verticals"><li><a rel="noreferrer" href="/"><span class="">Home</span></a></li><li><a rel="noreferrer" href="/vertical/politics"><span class="">politics</span></a></li><li><a rel="noreferrer" href="/vertical/business"><span class="">business</span></a></li><li><a rel="noreferrer" href="/vertical/tech"><span class="">technology</span></a></li><li><a rel="noreferrer" href="/vertical/netzero"><span class="">net zero</span></a></li><li><a rel="noreferrer" href="/vertical/africa"><span class="">africa</span></a></li><li><a rel="noreferrer" href="/vertical/security"><span class="">security</span></a></li><li><a rel="noreferrer" href="/vertical/media"><span class="">media</span></a></li><li><a rel="noreferrer" href="/hub/global-elections"><span class="long-title">Global Elections</span></a></li></ul><ul class="pages"><li><a href="/about">About</a><a href="https://semafor.com/speakers-bureau">Speakers Bureau</a><a href="/careers">Careers</a><a href="/hub/mixed-signals-media-podcast">Podcast</a></li></ul><div class="lower-band"><a class="privacy" href="/privacy">Privacy</a><span class="copy">Â© <!-- -->2024<!-- --> Semafor Inc.</span></div></div></div></div><div data-testid="mobile-slide-container" class="styles_mobileSlideContainer__7tYKH styles_closed__Z1AEK"></div><div class="styles_navContainer__Y5Xrw"><div class="styles_divider__xkDtO styles_mobileAndTabletDivider__wvoH9" aria-hidden="true"></div><ul class="styles_clocks__n9w6B styles_mobileClocks__g9d47"><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">D.C.</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Washington D.C."><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">BXL</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Brussels"><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">Lagos</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Lagos"><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">Dubai</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Dubai"><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">Beijing</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Beijing"><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">SG</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Singapore"><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li></ul><div class="styles_desktopSpacer__BIEM_"></div><div class="styles_dates__7Altw styles_desktopDate__LUs5n"><div class="styles_timeWrapper__xYsnW"><img data-testid="rotating-globe" alt="rotating globe" loading="lazy" width="12" height="12" decoding="async" data-nimg="1" class="styles_earthIcon___5xDc" style="color:transparent" src="https://static.semafor.com/_next/static/media/spinning-earth.eafcef04.gif"/><div></div></div><div></div></div><div class="styles_logoWrapper__DZcuq"><ul class="styles_clocks__n9w6B styles_tabletClocks__OTaXf"><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">D.C.</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Washington D.C."><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">BXL</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Brussels"><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">Lagos</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Lagos"><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li></ul><a class="styles_logoContainer__YRn0d" href="/"><img alt="Semafor Logo" loading="lazy" width="342" height="54" decoding="async" data-nimg="1" class="styles_logo__OCGaO" style="color:transparent" src="https://static.semafor.com/_next/static/media/homepage-semafor-text-logo.f6eb10d0.svg"/></a><ul class="styles_clocks__n9w6B styles_tabletClocks__OTaXf"><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">Dubai</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Dubai"><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">Beijing</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Beijing"><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li><li class="styles_timezone__2u_Dp"><span class="styles_timezoneTitle__d5G7w">SG</span><span class="styles_clock__EjLa8" role="figure" aria-label="clock showing estimated time in Singapore"><span class="styles_clockHand__aD9m9 styles_secondHand__mU64u" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_minuteHand__YqJRK" style="animation-delay:0s"></span><span class="styles_clockHand__aD9m9 styles_hourHand__KXlN0" style="animation-delay:0s"></span></span></li></ul></div><span class="styles_linkWrapper__cekBV styles_desktopLink__C4hJV"></span></div></header><div class="styles_container__8d8tI"><div class="styles_links__ZbYeq"><a href="/events" class="styles_navItem__iaHj4">Events</a><a href="/newsletters" class="styles_navItem__iaHj4">Newsletters</a></div><span>Intelligent</span><span>Transparent</span><span>Global</span><nav class="styles_nav__tGFtt styles_desktopNav__deD8U"><div class="styles_drawer__4P0Og styles_button__NsBiE"><button><img alt="Open navigation" loading="lazy" width="44" height="34" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/nav-open.bd13f47f.svg"/></button><button class="styles_mobileClose__CQma6 styles_closed__Z1AEK"><img alt="Close navigation" loading="lazy" width="44" height="34" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/nav-close.69baa99c.svg"/></button></div><div data-testid="flyin-container" class="styles_drawer__4P0Og styles_flyin__NChBU styles_closed__Z1AEK"><div data-testid="flyin-overlay" class="styles_overlay__1DZXc styles_closed__Z1AEK"><button class="styles_closeButton__p1R8q"><img alt="Close navigation" loading="lazy" width="44" height="34" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/nav-close.69baa99c.svg"/></button><div class="styles_menu__L2d8x styles_flyinMenu__ooq1p"><div class="container"><ul class="verticals"><li><a rel="noreferrer" href="/"><span class="">Home</span></a></li><li><a rel="noreferrer" href="/vertical/politics"><span class="">politics</span></a></li><li><a rel="noreferrer" href="/vertical/business"><span class="">business</span></a></li><li><a rel="noreferrer" href="/vertical/tech"><span class="">technology</span></a></li><li><a rel="noreferrer" href="/vertical/netzero"><span class="">net zero</span></a></li><li><a rel="noreferrer" href="/vertical/africa"><span class="">africa</span></a></li><li><a rel="noreferrer" href="/vertical/security"><span class="">security</span></a></li><li><a rel="noreferrer" href="/vertical/media"><span class="">media</span></a></li><li><a rel="noreferrer" href="/hub/global-elections"><span class="long-title">Global Elections</span></a></li></ul><ul class="pages"><li><ul><li><a target="_blank" rel="noreferrer" href="/events">Events</a></li><li><a target="_blank" rel="noreferrer" href="/newsletters">Newsletters</a></li><li><a target="_blank" rel="noreferrer" href="/hub/mixed-signals-media-podcast">Podcast</a></li></ul></li><li><ul><li><a href="/about">About</a></li><li><a href="https://semafor.com/speakers-bureau">Speakers Bureau</a></li><li><a href="/careers">Careers</a></li></ul></li><li><a href="/privacy">Privacy</a><div class="styles_copy__VZgiA">Â© <!-- -->2024<!-- --> Semafor Inc.</div></li></ul><a class="nav-logo" href="/"><img alt="Semafor Navigation Logo" loading="lazy" width="230" height="44" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/semafor-logo-long.d14b90e5.svg"/></a></div></div></div><div role="none" class="styles_overlayContainer__N8gtd styles_closed__Z1AEK"></div></div></nav></div><hr class="styles_tabletDivider__PxNa5"/><hr class="styles_tabletDivider__PxNa5"/><div class="styles_verticalNavContainer__bTQGs"><nav class="styles_nav__Nk0Cd" data-testid="vertical-nav"><a href="/" class="styles_navItem__z5ZML">Home</a><a href="/vertical/politics" class="styles_navItem__z5ZML">politics</a><a href="/vertical/business" class="styles_navItem__z5ZML">business</a><a href="/vertical/tech" class="styles_navItem__z5ZML">technology</a><a href="/vertical/netzero" class="styles_navItem__z5ZML">net zero</a><a href="/vertical/africa" class="styles_navItem__z5ZML">africa</a><a href="/vertical/security" class="styles_navItem__z5ZML">security</a><a href="/vertical/media" class="styles_navItem__z5ZML">media</a><a href="/hub/global-elections" class="styles_navItem__z5ZML">Global Elections</a></nav><hr class="styles_bottomDivider__UQXAI"/></div></div></div><main class="styles_main__2i7CI" data-testid="article-layout"><div class="styles_columnDisplay__NEMWq styles_twoColumnDisplay__DS17H"><div class="styles_firstColumn__dHfHz"><div class="styles_authorBlock__MIrJF"><div class="styles_wrapper__qC1H_"><div class="styles_content__svEG2"><div class="styles_authorImageWrapper__4W9NX"><img alt="Alexis Akwagyiram" loading="lazy" width="34" height="34" decoding="async" data-nimg="1" style="color:transparent" srcSet="https://img.semafor.com/a00cce649638d4c47c94beeec22ea4c01c2e29d8-1504x1600.jpg?auto=format&amp;w=48&amp;q=75 1x, https://img.semafor.com/a00cce649638d4c47c94beeec22ea4c01c2e29d8-1504x1600.jpg?auto=format&amp;w=96&amp;q=75 2x" src="https://img.semafor.com/a00cce649638d4c47c94beeec22ea4c01c2e29d8-1504x1600.jpg?auto=format&amp;w=96&amp;q=75"/></div><div class="styles_authorNameWrapper__BckRf styles_authorFlex__0FeC_"><span class="styles_authorName__nDYcq"><a href="/author/alexis-akwagyiram">Alexis Akwagyiram</a></span><div class="styles_authorTitle__5KgbT"></div></div></div></div><div class="styles_divider__xkDtO" aria-hidden="true"></div></div><div class="styles_wrapper__OZ9ZE"><div class="styles_leftCol__IZoTN"><div data-testid="date" class="styles_date__CkxLh">Updated <noscript>May 23, 2024, 9:37am EDT</noscript>May 23, 2024, 9:37am EDT</div><a class="styles_tag__tMXSX" href="/vertical/africa">africa</a></div><div class="styles_mobileShare__QxoWJ"><div class="styles_container__EgE_f"><style data-emotion="css 1wfw2s5">.css-1wfw2s5{text-transform:uppercase;font-weight:bold;-webkit-text-decoration:underline;text-decoration:underline;background:none;border:none;color:#243bb5;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;gap:4px;padding:10px;-webkit-box-flex-wrap:nowrap;-webkit-flex-wrap:nowrap;-ms-flex-wrap:nowrap;flex-wrap:nowrap;font-family:Helvetica;font-size:0.8125rem;line-height:120%;}.css-1wfw2s5:hover{cursor:pointer;}</style><button aria-label="Open share interface" class="css-1wfw2s5">Share<svg width="20" height="15" viewBox="0 0 20 15" fill="none" xmlns="http://www.w3.org/2000/svg" style="width:1.25rem;height:0.9375rem;margin-bottom:0.1875rem"><path d="M15.922 5.55274C15.7589 5.10185 15.6294 4.69414 15.5335 4.32959C15.4472 3.95545 15.3944 3.62448 15.3752 3.33668L6.98582 11.7261L6.38144 11.1217L14.7708 2.7323C14.4734 2.70352 14.1377 2.64596 13.7635 2.55962C13.399 2.46368 12.9961 2.33897 12.5548 2.18548L13.0584 1.68183C14.3631 1.77776 15.5143 1.66264 16.512 1.33647L16.771 1.59549C16.4353 2.5836 16.3201 3.7348 16.4257 5.04909L15.922 5.55274Z" fill="currentColor"></path><path d="M11.5 3.7832H4.5V13.2832H13.5V7.7832" stroke="currentColor"></path></svg></button></div></div></div><h1 class="styles_title__QYh49">South Africaâs Afrigen targets local diseases with mRNA vaccines</h1><div class="styles_figureContainer__QKVg_"><figure class="styles_figure__mP_zS"><img alt="" data-testid="ledeImage" loading="lazy" width="700" height="476" decoding="async" data-nimg="1" class="styles_image__TlE9w" style="color:transparent" srcSet="https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?w=750&amp;q=75&amp;auto=format 1x, https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?w=1920&amp;q=75&amp;auto=format 2x" src="https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?w=1920&amp;q=75&amp;auto=format"/><figcaption class="styles_imageAttribution__FZw9F styles_imageAttr__LX92r">Nicky Lloyd/Getty Images</figcaption></figure></div><div class=""><div class="styles_container__X90Lh styles_container__84she"><div class="styles_shareWrapper__YPlqA"><style data-emotion="css 1dtnjt5">.css-1dtnjt5{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-flex-wrap:wrap;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;}</style><div class="css-1dtnjt5"><style data-emotion="css 1hu9vey">.css-1hu9vey{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;gap:4px;padding:10px;-webkit-box-flex-wrap:nowrap;-webkit-flex-wrap:nowrap;-ms-flex-wrap:nowrap;flex-wrap:nowrap;font-family:Helvetica;font-size:0.8125rem;line-height:120%;color:#53524c;-webkit-text-decoration:none;text-decoration:none;}.css-1hu9vey:hover{cursor:pointer;}</style><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.semafor.com%2Farticle%2F05%2F23%2F2024%2Fsouth-africas-afrigen-targets-local-diseases-with-mrna-vaccines&amp;text=South%20Africa%E2%80%99s%20Afrigen%20targets%20local%20diseases%20with%20mRNA%20vaccines" aria-label="Share with Twitter" target="_blank" rel="noopener noreferrer" class="css-1hu9vey"><svg width="20" height="16" viewBox="0 0 20 16" fill="none" xmlns="http://www.w3.org/2000/svg" style="width:1.25rem;height:0.9375rem;margin-bottom:0.125rem"><path d="M10.5119 7.1067L14.4715 2.16666H13.5332L10.0951 6.45603L7.34905 2.16666H4.18182L8.33437 8.65294L4.18182 13.8333H5.12018L8.75095 9.30362L11.651 13.8333H14.8182L10.5117 7.1067H10.5119ZM9.2267 8.71009L8.80596 8.0642L5.45828 2.92481H6.89955L9.60116 7.07246L10.0219 7.71835L13.5337 13.1097H12.0924L9.2267 8.71034V8.71009Z" fill="#53524C"></path></svg>Post</a><a href="mailto:?subject=South%20Africa%E2%80%99s%20Afrigen%20targets%20local%20diseases%20with%20mRNA%20vaccines%20%7C%20Semafor&amp;body=https://www.semafor.com/article/05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines" aria-label="Share with Email" target="_blank" rel="noopener noreferrer" class="css-1hu9vey"><svg width="20" height="15" viewBox="0 0 20 15" fill="none" xmlns="http://www.w3.org/2000/svg" style="width:1.25rem;height:0.9375rem;margin-bottom:0.125rem"><rect width="20" height="14" transform="translate(0 0.740479)" fill="none"></rect><path d="M4 3.74048V11.7405H16V3.74048M4 3.74048H16M4 3.74048L10 8.74048L16 3.74048" stroke="currentColor" stroke-width="0.75"></path></svg>Email</a><a href="https://wa.me/?text=South%20Africa%E2%80%99s%20Afrigen%20targets%20local%20diseases%20with%20mRNA%20vaccines%20https%3A%2F%2Fwww.semafor.com%2Farticle%2F05%2F23%2F2024%2Fsouth-africas-afrigen-targets-local-diseases-with-mrna-vaccines" aria-label="Share with Whatsapp" target="_blank" rel="noopener noreferrer" class="css-1hu9vey"><svg width="20" height="15" viewBox="0 0 20 15" fill="none" xmlns="http://www.w3.org/2000/svg" style="width:1.25rem;height:0.9375rem;margin-bottom:0.125rem"><rect width="20" height="14" transform="translate(0 0.740479)" fill="none"></rect><path d="M4 13.4868L4.84277 10.3559C4.1631 9.13632 3.94716 7.71313 4.23458 6.34752C4.522 4.98191 5.2935 3.76548 6.40751 2.92146C7.52151 2.07744 8.90331 1.66244 10.2993 1.7526C11.6953 1.84277 13.0119 2.43206 14.0075 3.41234C15.0031 4.39261 15.6109 5.69812 15.7193 7.0893C15.8278 8.48048 15.4296 9.86401 14.5979 10.986C13.7662 12.108 12.5568 12.8932 11.1915 13.1976C9.82628 13.5019 8.39679 13.3049 7.16536 12.6428L4 13.4868ZM7.31799 11.4713L7.51375 11.5871C8.4057 12.1144 9.44748 12.3326 10.4767 12.2077C11.506 12.0828 12.4649 11.6218 13.2041 10.8966C13.9433 10.1713 14.4212 9.22252 14.5633 8.19807C14.7054 7.17361 14.5038 6.13104 13.9898 5.23281C13.4759 4.33459 12.6785 3.63117 11.7219 3.23218C10.7653 2.83319 9.70327 2.76103 8.70128 3.02696C7.69929 3.29289 6.81363 3.88196 6.18232 4.70237C5.55102 5.52279 5.20953 6.52846 5.21107 7.56268C5.21023 8.42021 5.44799 9.26115 5.89789 9.99189L6.02066 10.1938L5.5495 11.9412L7.31799 11.4713Z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M12.0693 8.3666C11.9545 8.27427 11.8201 8.20929 11.6764 8.1766C11.5326 8.14391 11.3833 8.14437 11.2398 8.17795C11.0241 8.26731 10.8847 8.60488 10.7454 8.77367C10.716 8.81413 10.6728 8.84251 10.6239 8.85348C10.5751 8.86445 10.5239 8.85725 10.4799 8.83324C9.69037 8.52478 9.02855 7.95911 8.60196 7.22811C8.56558 7.18249 8.54836 7.12457 8.55393 7.06655C8.5595 7.00852 8.58742 6.95491 8.63182 6.91701C8.78725 6.76354 8.90137 6.57344 8.96362 6.36432C8.97745 6.13365 8.92446 5.90388 8.811 5.70241C8.72327 5.41996 8.55633 5.16845 8.32989 4.97761C8.21309 4.92522 8.0836 4.90765 7.95702 4.92703C7.83044 4.94641 7.71218 5.00191 7.61652 5.08683C7.45044 5.22975 7.31862 5.40801 7.23077 5.60848C7.14291 5.80895 7.10125 6.02652 7.10887 6.24517C7.10938 6.36796 7.12498 6.49022 7.15532 6.60922C7.23236 6.89514 7.35085 7.1683 7.50702 7.42006C7.6197 7.61292 7.74264 7.79962 7.87532 7.97938C8.30651 8.5698 8.84852 9.07109 9.47128 9.45544C9.78378 9.65075 10.1178 9.80955 10.4667 9.9287C10.8291 10.0926 11.2293 10.1555 11.6247 10.1107C11.8499 10.0767 12.0634 9.988 12.2462 9.85238C12.429 9.71676 12.5756 9.5384 12.6731 9.33298C12.7304 9.2089 12.7478 9.07017 12.7229 8.93584C12.6632 8.66115 12.2949 8.49898 12.0693 8.3666Z" fill="currentColor"></path></svg>Whatsapp</a><style data-emotion="css 6hf1pk">.css-6hf1pk{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;gap:4px;padding:10px;-webkit-box-flex-wrap:nowrap;-webkit-flex-wrap:nowrap;-ms-flex-wrap:nowrap;flex-wrap:nowrap;font-family:Helvetica;font-size:0.8125rem;line-height:120%;color:#53524c;background:none;border:none;}.css-6hf1pk:hover{cursor:pointer;}</style><button class="css-6hf1pk"><style data-emotion="css h3t4g5">.css-h3t4g5{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-content:center;-ms-flex-line-pack:center;align-content:center;gap:4px;}</style><span class="css-h3t4g5"><svg width="20" height="15" viewBox="0 0 20 15" fill="none" xmlns="http://www.w3.org/2000/svg" style="width:1.25rem;height:0.9375rem;margin-bottom:0.125rem"><rect width="20" height="14" transform="translate(0 0.740479)" fill="none"></rect><path d="M7.51897 12.7405C7.05362 12.7405 6.62873 12.6277 6.24431 12.402C5.87001 12.1661 5.56651 11.8584 5.33384 11.4789C5.11128 11.0892 5 10.6584 5 10.1866C5 9.71484 5.11128 9.2892 5.33384 8.90971C5.56651 8.51997 5.87001 8.21227 6.24431 7.98663C6.62873 7.75074 7.05362 7.63279 7.51897 7.63279C7.77188 7.63279 8.01467 7.67381 8.24734 7.75586C8.49014 7.82766 8.72281 7.94048 8.94537 8.09432L10.3566 6.66356C10.2251 6.46868 10.1239 6.25843 10.0531 6.03279C9.99241 5.79689 9.96206 5.55074 9.96206 5.29432C9.96206 4.83279 10.0733 4.40715 10.2959 4.0174C10.5286 3.62766 10.8321 3.31997 11.2064 3.09432C11.5908 2.85843 12.0157 2.74048 12.481 2.74048C12.9464 2.74048 13.3662 2.85843 13.7405 3.09432C14.1249 3.31997 14.4284 3.62766 14.651 4.0174C14.8837 4.40715 15 4.83279 15 5.29432C15 5.75586 14.8837 6.1815 14.651 6.57125C14.4284 6.96099 14.1249 7.27381 13.7405 7.50971C13.3662 7.73535 12.9464 7.84817 12.481 7.84817C12.218 7.84817 11.9651 7.81227 11.7223 7.74048C11.4795 7.65843 11.2418 7.53535 11.0091 7.37125L9.61305 8.78663C9.75468 8.99176 9.8609 9.21227 9.93171 9.44817C10.0025 9.68407 10.0379 9.93022 10.0379 10.1866C10.0379 10.6482 9.9216 11.0738 9.68892 11.4636C9.46636 11.8533 9.16287 12.1661 8.77845 12.402C8.40415 12.6277 7.98432 12.7405 7.51897 12.7405ZM7.51897 11.7866C7.80223 11.7866 8.06019 11.7148 8.29287 11.5712C8.53566 11.4277 8.72787 11.2328 8.8695 10.9866C9.02124 10.7405 9.09712 10.4738 9.09712 10.1866C9.09712 9.8892 9.02124 9.62253 8.8695 9.38663C8.72787 9.14048 8.53566 8.94561 8.29287 8.80202C8.06019 8.65843 7.80223 8.58663 7.51897 8.58663C7.24583 8.58663 6.98786 8.65843 6.74507 8.80202C6.50228 8.94561 6.30501 9.14048 6.15326 9.38663C6.01163 9.62253 5.94082 9.8892 5.94082 10.1866C5.94082 10.4738 6.01163 10.7405 6.15326 10.9866C6.29489 11.2225 6.4871 11.4174 6.72989 11.5712C6.97269 11.7148 7.23571 11.7866 7.51897 11.7866ZM12.481 6.89432C12.7643 6.89432 13.0223 6.82253 13.2549 6.67894C13.4977 6.53535 13.6899 6.34048 13.8316 6.09432C13.9833 5.84817 14.0592 5.5815 14.0592 5.29432C14.0592 5.0174 13.9884 4.75586 13.8467 4.50971C13.7051 4.26356 13.5129 4.06868 13.2701 3.92509C13.0374 3.77125 12.7744 3.69433 12.481 3.69433C12.1978 3.69433 11.9347 3.77125 11.692 3.92509C11.4492 4.06868 11.257 4.26356 11.1153 4.50971C10.9737 4.74561 10.9029 5.00715 10.9029 5.29432C10.9029 5.5815 10.9737 5.84817 11.1153 6.09432C11.2671 6.34048 11.4593 6.53535 11.692 6.67894C11.9347 6.82253 12.1978 6.89432 12.481 6.89432Z" fill="currentColor"></path></svg>CopyÂ link</span></button></div></div></div></div></div><div class="styles_secondColumn__z_o93"><div class="styles_navMenuWrapper__AjoHY"><div><form id="inline-africa-form" class="styles_form__Ja4LQ liveramp-inline-signup-form" noValidate=""><input type="text" data-testid="hidden-newsletter" aria-hidden="true" readOnly="" hidden="" name="newsletter" value="africa"/><p class="styles_intro__VdMFa styles_intro__uJGWQ"><b class="styles_bold__iCS55">Sign up for Semafor Africa:</b> <!-- -->A rapidly-growing continentâs crucial stories.<!-- --> <a href="/newsletters/africa/latest" aria-label="Read the latest africa newsletter">Read it now</a>.</p><fieldset class="styles_fieldset__w7oGb"><label class="styles_hiddenLabel__AQc10" for="newsletter-sign-up-:R7d5brnnnlata:">Your Email address</label><input placeholder="Your Email address" id="newsletter-sign-up-:R7d5brnnnlata:" autoComplete="email" aria-invalid="false" type="email" class="styles_emailInput__1fIkY" required="" name="email" value=""/><button class="styles_signUpButton__yraUk">SignÂ Up</button><div id="inline-newsletter-feedback" class="styles_feedback__1GX0T styles_right__NJMz0 undefined" aria-hidden="true"></div></fieldset></form></div><div class="styles_indexMenuWrapper__n5Np9"><div class="styles_indexMenu__t9Arm"><p class="styles_indexMenuTitle__YLM69">In this article:</p><div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="The Scoop" href="#the-scoop"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/thenews@2x.f322bda2.png"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">The Scoop</h3></div></a></div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="Know More" href="#know-more"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/knowmore.67924317.svg"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">Know More</h3></div></a></div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="Alexisâs view" href="#alexiss-view"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/reporterstake@2x.a8a90336.png"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">Alexisâs view</h3></div></a></div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="Room for Disagreement" href="#room-for-disagreement"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/roomfordisagreement@2x.8c162eb3.png"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">Room for Disagreement</h3></div></a></div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="The View From Central African Republic" href="#the-view-from-central-african-republic"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/viewfrom@2x.b3a421ed.png"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">The View From Central African Republic</h3></div></a></div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="Notable" href="#notable"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/furtherreading@2x.4cfb1221.png"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">Notable</h3></div></a></div></div></div></div></div></div><div class="styles_divider__XYw_Z"></div></div><div class="styles_container__X90Lh article-content"><div class="styles_contentWrapper__Y7ec7 styles_articleContent__hNTEo"><div><div class=""><div class="styles_divider__xkDtO styles_divider__tPDrE styles_firstSection__J2y_N styles_twoColumnFirstContent__kSAAg" aria-hidden="true"></div><div class="style_title__n4CiQ"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/thenews@2x.f322bda2.png"/><h3 id="the-scoop" class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK style_isPrimary__amLBT">The Scoop</h3></div><div class="styles_text__lvCVh"><p>KIGALI, Rwanda â South African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist to develop groundbreaking gene therapy treatments that target diseases that have plagued Africa for decades.</p><p>The Cape Town-based company is working with the University of Pennsylvaniaâs Drew Weissman, who won a Nobel Prize for developing mRNA vaccines used to fight COVID-19.</p><p>âMy people are in his labs working with some of his top scientists on mRNA. And, of course, we are extremely interested to further collaborate,â Afrigen CEO Petro Terblanche told Semafor Africa. She said the company is exploring âopportunities to bring gene therapy to Africaâ through its ties with scientists at University of Pennsylvania.</p><div class="styles_divider__xkDtO styles_adDivider__aXGYy styles_topDivider__FcDpP" aria-hidden="true"></div><div data-testid="ad-body" class="styles_adMargin__bnZWC"><div data-testid="ad-label" class="styles_adLabel__UBLx0">AD</div><div data-testid="ad-container" class="styles_adContainer__X2SPy"><div class="styles_innerAdContainer__InIPz"><div id="ad-block-1" class="styles_ad__ECTuS" data-testid="ad" data-ad-density="true"></div></div></div></div><div class="styles_divider__xkDtO styles_adDivider__aXGYy styles_bottomDivider__6uqU_" aria-hidden="true"></div><p>Gene therapy refers to forms of treatment that add a new gene or repair a mutated one inside the human body.</p><p>Treatments for <a href="https://www.semafor.com/newsletter/12/21/2023/ghana-detty-december-tourists-revenue?utm_source=nowshare&amp;utm_medium=africa&amp;utm_campaign=Briefing#e" class="styles_linkEmbed__SNmaX" rel="no-referrer">sickle cell disease</a>, a condition that mostly afflicts people of African descent, have been approved by US authorities in recent months. Gene therapy treatments are also being developed to treat <a href="https://hms.harvard.edu/news/gene-editing-improves-vision-some-people-inherited-blindness" class="styles_linkEmbed__SNmaX" rel="no-referrer">blindness</a> and <a href="https://www.npr.org/sections/health-shots/2024/01/24/1226595039/gene-therapy-shows-promise-for-an-inherited-form-of-deafness" class="styles_linkEmbed__SNmaX" rel="no-referrer">deafness</a>.</p></div></div></div><div class="styles_indexMenu__ggYd1"><p class="styles_indexMenuTitle__YLM69">In this article:</p><div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="The Scoop" href="#the-scoop"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/thenews@2x.f322bda2.png"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">The Scoop</h3></div></a></div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="Know More" href="#know-more"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/knowmore.67924317.svg"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">Know More</h3></div></a></div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="Alexisâs view" href="#alexiss-view"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/reporterstake@2x.a8a90336.png"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">Alexisâs view</h3></div></a></div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="Room for Disagreement" href="#room-for-disagreement"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/roomfordisagreement@2x.8c162eb3.png"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">Room for Disagreement</h3></div></a></div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="The View From Central African Republic" href="#the-view-from-central-african-republic"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/viewfrom@2x.b3a421ed.png"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">The View From Central African Republic</h3></div></a></div><div class="styles_indexMenuBlock__yrUhY"><a aria-label="Notable" href="#notable"><div class="style_title__n4CiQ styles_navTitleWrapper__MWwM9"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/furtherreading@2x.4cfb1221.png"/><h3 class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK styles_navTitle__3V6oh">Notable</h3></div></a></div></div></div></div><div class="styles_contentWrapper__Y7ec7 styles_articleContent__hNTEo"><div><div class=""><div class="styles_divider__xkDtO styles_divider__tPDrE" aria-hidden="true"></div><div class="style_title__n4CiQ"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/knowmore.67924317.svg"/><h3 id="know-more" class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK style_isPrimary__amLBT">Know More</h3></div><div class="styles_text__lvCVh"><p>Afrigenâs model involves developing the technology and expertise to create vaccines and therapeutic drugs which it then shares with partner manufacturers. It has a mandate to share technology and expertise with vaccine producers and research institutions under an initiative backed by the World Health Organization.</p><div class="styles_divider__xkDtO styles_adDivider__aXGYy styles_topDivider__FcDpP" aria-hidden="true"></div><div data-testid="ad-body" class="styles_adMargin__bnZWC"><div data-testid="ad-label" class="styles_adLabel__UBLx0">AD</div><div data-testid="ad-container" class="styles_adContainer__X2SPy"><div class="styles_innerAdContainer__InIPz"><div id="ad-block-2" class="styles_ad__ECTuS" data-testid="ad" data-ad-density="true"></div></div></div></div><div class="styles_divider__xkDtO styles_adDivider__aXGYy styles_bottomDivider__6uqU_" aria-hidden="true"></div><p>Terblanche, speaking to Semafor Africa on the sidelines of the Africa CEO Forum in Kigali, said the company shared information with 15 partners â made up of vaccine manufacturers and research institutions â in South Africa, Senegal, Nigeria, Kenya, Tunisia, and Egypt.</p><p>She said Afrigen is developing a new generation of mRNA vaccines for a range of diseases including HIV, tuberculosis (TB), Rift Valley fever, and gonorrhea.</p><p>Afrigen needs âa pipeline of productsâ that can be produced on an mRNA platform, Terblanche told Semafor Africa. âAs we move these through the pipeline we will continue to focus on diseases which are a priority for the region,â she said.</p><div class="styles_divider__xkDtO styles_adDivider__aXGYy styles_topDivider__FcDpP" aria-hidden="true"></div><div data-testid="ad-body" class="styles_adMargin__bnZWC"><div data-testid="ad-label" class="styles_adLabel__UBLx0">AD</div><div data-testid="ad-container" class="styles_adContainer__X2SPy"><div class="styles_innerAdContainer__InIPz"><div id="ad-block-3" class="styles_ad__ECTuS" data-testid="ad" data-ad-density="true"></div></div></div></div><div class="styles_divider__xkDtO styles_adDivider__aXGYy styles_bottomDivider__6uqU_" aria-hidden="true"></div><p>Vaccines based on messenger ribonucleic acid (mRNA) technology train the immune system to recognize and fight threats. Weissman, whose laboratory is developing gene therapy for sickle cell disease, has previously spoken of the potential to <a href="https://www.forbes.com/sites/juergeneckhardt/2023/11/16/nobel-winner-drew-weissman-shares-7-insights-on-future-mrna-breakthroughs/" class="styles_linkEmbed__SNmaX" rel="no-referrer">harness mRNA technology</a> to produce relatively cheap vaccines and therapeutic treatments that can be rolled out in low and middle income countries.</p></div></div></div></div><div class="styles_contentWrapper__Y7ec7 styles_articleContent__hNTEo"><div><div class=""><div class="styles_divider__xkDtO styles_divider__tPDrE" aria-hidden="true"></div><div class="style_title__n4CiQ"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/reporterstake@2x.a8a90336.png"/><h3 id="alexiss-view" class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK style_isPrimary__amLBT">Alexisâs view</h3></div><div class="styles_text__lvCVh"><p>The COVID-19 pandemic taught us so much. The early scramble for vaccines was a stark glimpse of global power dynamics, as wealthy nations secured access to the first shots when the world teetered on the brink of uncertainty. But the pandemic also spurred incredible innovation.</p><p>The takeaway from both lessons was the same: African countries need to manufacture more vaccines and drugs locally. Thatâs why the African Union has set a target of 60% of vaccines, therapeutics, and other medical products being manufactured locally by 2040. And international vaccine group Gavi in December approved a financing instrument that will make up to $1 billion available to support vaccine manufacturing in Africa.</p><p>In mRNA technology, the continent has an opportunity to harness an innovative form of treatment that, with time and investment, has the potential to lower the cost of healthcare. Thatâs because these treatments could offer protection against a broad range of diseases that have previously been ignored. Many conditions, from sickle cell to malaria and HIV, could one day be treated with as little as a single injection.</p><p>Obviously, this is important on a human level because of the physical and mental anguish illnesses can cause for sufferers and their loved ones. We often talk about Africaâs relative youth, compared to other parts of the world. But itâs also important to ensure that future generations are healthy.</p><p>But none of this will be easy. The collaborations involving Afrigen are just the start of a process that could take years and would need the backing of governments and global health bodies. The potential impact can be realized, but African countries need to build their biotech sectors to make it happen.</p></div></div></div></div><div class="styles_contentWrapper__Y7ec7 styles_articleContent__hNTEo"><div><div class=""><div class="styles_divider__xkDtO styles_divider__tPDrE" aria-hidden="true"></div><div class="style_title__n4CiQ"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/roomfordisagreement@2x.8c162eb3.png"/><h3 id="room-for-disagreement" class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK style_isPrimary__amLBT">Room for Disagreement</h3></div><div class="styles_text__lvCVh"><p>At present, mRNA vaccines typically must be stored at very cold temperatures of minus 20 C to minus 80 C (minus 4 F to minus 112 F), which drives up the cost. The temperature requirements have been a barrier to entry in poorer countries which lack such refrigeration facilities.</p><p>Terblanche said Afrigen and its partners had developed processes to ensure thermostability of products between 2 C and 8 C (35.6 F and 46.4 F). âWeâre working with partners to innovate around the current mRNA vaccine because that also reduces the cost,â she said.</p></div></div></div></div><div class="styles_contentWrapper__Y7ec7 styles_articleContent__hNTEo"><div><div class=""><div class="styles_divider__xkDtO styles_divider__tPDrE" aria-hidden="true"></div><div class="style_title__n4CiQ"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/viewfrom@2x.b3a421ed.png"/><h3 id="the-view-from-central-african-republic" class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK style_isPrimary__amLBT">The View From Central African Republic</h3></div><div class="styles_text__lvCVh"><p>Forms of gene therapy âcould revolutionize medical care in Africaâ by enabling patients to receive cures âin countries that still need time to develop comprehensive healthcare systems, said Yap Boum II, executive director of the Institut Pasteur de Bangui.</p><p>He said investment in training programs to develop local expertise in mRNA technology would be âessentialâ for it to be taken up, adding that âharmonizing and simplifying regulatory frameworks across the continentâ would expedite the approval and implementation of new technologies.</p><p>Boum told Semafor Africa the widespread deployment of techniques like mRNA technology âwill take yearsâ because it would only follow the building of human capacity and the sharing of technology, which would require investment.</p></div></div></div></div><div class="styles_contentWrapper__Y7ec7 styles_articleContent__hNTEo"><div><div class=""><div class="styles_divider__xkDtO styles_divider__tPDrE" aria-hidden="true"></div><div class="style_title__n4CiQ"><img alt="Title icon" loading="lazy" width="20" height="16" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/furtherreading@2x.4cfb1221.png"/><h3 id="notable" class="style_title__n4CiQ style_titleText__oyJ9f style_withTitleIcon__VPxdK style_isPrimary__amLBT">Notable</h3></div><div class="styles_text__lvCVh"><ul class="styles_list__bFxuC"><li class="styles_li__edKIA"><strong class="styles_strong__CyLpx">Moderna</strong> <strong class="styles_strong__CyLpx">last month said it had put on hold</strong> plans to build a mRNA vaccine <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-puts-kenya-plant-plans-hold-covid-vaccine-demand-slumps-2024-04-11/" class="styles_linkEmbed__SNmaX" rel="no-referrer">manufacturing plant</a> in Kenya. The Africa Centres for Disease Control and Prevention accused the US biotech company of <a href="https://africacdc.org/news-item/africa-cdcs-statement-on-modernas-plan-to-reassess-commitment-to-african-vaccine-manufacturing/" class="styles_linkEmbed__SNmaX" rel="no-referrer">âabandoningâ its commitment</a> to vaccine equity.</li></ul></div></div></div></div><div class="styles_wrapperMargin__tMuyr"><div class="styles_image__BBKoH"><img alt="Semafor Logo" loading="lazy" width="19" height="19" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/semafor-logo-small.cc0a7c9c.svg"/></div><div class="styles_borders__Jkl36"></div></div><div></div><section class="styles_recircContainer__ub2bB"></section></div></main><div class="styles_divider__xkDtO styles_adDivider__JOzkU" aria-hidden="true"></div><div data-testid="ad-body" class="styles_adMargin__bnZWC"><div data-testid="ad-label" class="styles_adLabel__UBLx0">AD</div><div data-testid="ad-container" class="styles_adContainer__X2SPy"><div class="styles_innerAdContainer__InIPz"><div id="ad-footer" class="styles_ad__ECTuS" data-testid="ad" data-ad-density="true"></div></div></div></div><div class="styles_divider__xkDtO styles_adDivider__JOzkU styles_bottomDivider__26Kv_" aria-hidden="true"></div><div class="styles_container__dNZq9"><footer class="styles_footer__p9ejH" data-testid="footer"><nav class="styles_nav__LshBq"><div class="styles_logoLink__2RLAj"><a href="/"><img alt="Semafor Logo" loading="lazy" width="153" height="20" decoding="async" data-nimg="1" style="color:transparent" src="https://static.semafor.com/_next/static/media/semafor-logo-long.d14b90e5.svg"/></a></div><a class="styles_navItem__y1u7T" href="/newsletters">Newsletters</a><a class="styles_navItem__y1u7T" href="/events">Events</a><a class="styles_navItem__y1u7T" target="_blank" href="https://www.youtube.com/channel/UCtB4ylCuQW0ue8ACIsHmD1w" rel="noreferrer">YouTube</a><a class="styles_navItem__y1u7T" target="_blank" href="https://twitter.com/semafor" rel="noreferrer">Twitter</a><a class="styles_navItem__y1u7T" target="_blank" href="https://www.facebook.com/semaformedia" rel="noreferrer">Facebook</a><a class="styles_navItem__y1u7T" href="/about">About</a><a class="styles_navItem__y1u7T" href="/careers">Careers</a><a class="styles_navItem__y1u7T" href="/privacy">Privacy</a><div class="styles_copy__3jw4k"><span>Â© <!-- -->2024<!-- --> Semafor Inc.</span></div></nav></footer></div><style data-emotion="css 1dqzate">.css-1dqzate{position:fixed;top:0;left:0;right:0;width:100%;bottom:100%;z-index:900;}</style><div class="css-1dqzate"></div><style data-emotion="css 1m3i90g animation-1cwuobz">.css-1m3i90g{padding:0 10px;position:fixed;bottom:0;right:0;left:0;z-index:901;font-family:"FeatureFlatHeadline",serif;background-color:#f8f5d7;-webkit-transform:translate(0%, 101%);-moz-transform:translate(0%, 101%);-ms-transform:translate(0%, 101%);transform:translate(0%, 101%);-webkit-transition:-webkit-transform 0.3s ease-in-out;transition:transform 0.3s ease-in-out;}.css-1m3i90g[aria-hidden="true"]{-webkit-animation:animation-1cwuobz 0.3s ease-in-out forwards;animation:animation-1cwuobz 0.3s ease-in-out forwards;}@-webkit-keyframes animation-1cwuobz{0%,99%{visibility:visible;}100%{visibility:hidden;}}@keyframes animation-1cwuobz{0%,99%{visibility:visible;}100%{visibility:hidden;}}</style><div data-testid="newsletter-barrier" aria-hidden="true" class="css-1m3i90g"><style data-emotion="css 15iwn6">.css-15iwn6{border-top:1px dashed #1f1d1a;height:1px;width:100%;margin-top:10px;margin-top:0;max-width:878px;margin:0 auto 10px;}</style><div class="css-15iwn6"></div><style data-emotion="css aqq7fo">.css-aqq7fo{background:none;border:none;cursor:pointer;margin:0 auto;display:block;margin-bottom:20px;}</style><button type="button" aria-label="Close" class="css-aqq7fo"><svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http://www.w3.org/2000/svg"><rect width="22" height="22" rx="11" fill="#53524C"></rect><rect width="11.9391" height="0.308769" transform="matrix(0.67828 -0.734803 0.67828 0.734803 6.8457 15.7734)" fill="#53524C" stroke="#F8F5D7"></rect><rect width="11.9391" height="0.308769" transform="matrix(-0.67828 -0.734803 0.67828 -0.734803 14.9434 16)" fill="#53524C" stroke="#F8F5D7"></rect></svg></button><style data-emotion="css 1oxmwkh">.css-1oxmwkh{width:100%;max-width:540px;margin:0 auto;}</style><form class="liveramp-newsletter-signup-barrier css-1oxmwkh" id="newsletter-sign-up-barrier" noValidate=""><input type="text" aria-hidden="true" readOnly="" hidden="" name="newsletter" value="africa"/><style data-emotion="css ec2iqt">.css-ec2iqt{font-variation-settings:"wght" 400;font-weight:400;letter-spacing:0.02em;grid-area:intro;margin:0;color:#000000;margin-bottom:20px;}.css-ec2iqt a{-webkit-text-decoration:underline;text-decoration:underline;color:black;}</style><div class="css-ec2iqt"><style data-emotion="css yluo3e">.css-yluo3e{font-weight:395;font-variation-settings:"wght" 495,"opsz" 10;font-size:2rem;line-height:120%;margin:0 0 20px 0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:flex-start;-webkit-box-align:flex-start;-ms-flex-align:flex-start;align-items:flex-start;-webkit-box-pack:justify;-webkit-justify-content:space-between;justify-content:space-between;outline:none;}</style><p tabindex="-1" id="barrier-title" class="css-yluo3e"><span>Sign up for Semafor<!-- --> <style data-emotion="css w8sqnb">.css-w8sqnb{text-transform:capitalize;}</style><span class="css-w8sqnb">africa</span></span><img alt="" loading="lazy" width="25" height="28" decoding="async" data-nimg="1" style="color:transparent;height:28px;width:25px;margin:5px 10px" src="https://static.semafor.com/_next/static/media/icon-africa.17b48676.svg"/></p><style data-emotion="css 1budjld">.css-1budjld{font-variation-settings:"wght" 600;font-weight:500;letter-spacing:0.02em;}</style><b class="css-1budjld">A rapidly-growing continentâs crucial stories.<br/></b>In your inbox, 3 times per week.<!-- --> <a href="/newsletters/africa/latest" aria-label="Read the latest africa newsletter">Read it now</a>.</div><style data-emotion="css r4iybe">.css-r4iybe{background-color:#ffff00;font-family:"Helvetica";font-size:1rem;line-height:120%;padding:4px 4px 2px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;}</style><label for="newsletter-sign-up-:R7elrnnnlata:" class="css-r4iybe">Email address</label><div style="position:relative"><style data-emotion="css 8jslfv">.css-8jslfv{background-color:#fcfae4;border:1px solid #1f1d1a;padding:10px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;gap:10px;position:relative;z-index:2;}</style><div class="css-8jslfv"><svg width="20" height="17" viewBox="0 0 20 17" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M4 4.5V12.5H16V4.5M4 4.5H16M4 4.5L10 9.5L16 4.5" stroke="#1F1D1A" stroke-width="0.75"></path></svg><style data-emotion="css rbiwe3">.css-rbiwe3{font-size:1rem;line-height:120%;margin:0;font-variation-settings:"wght" 400;font-weight:400;font-family:"FeatureFlatHeadline",serif;border-radius:0;color:#000000;border:0;background-color:#fcfae4;width:100%;padding:0;}.css-rbiwe3::-webkit-input-placeholder{color:#9c9a92;}.css-rbiwe3::-moz-placeholder{color:#9c9a92;}.css-rbiwe3:-ms-input-placeholder{color:#9c9a92;}.css-rbiwe3::placeholder{color:#9c9a92;}.css-rbiwe3:focus{outline:0;}.css-rbiwe3[aria-invalid="true"]{color:#d79987;}</style><input id="newsletter-sign-up-:R7elrnnnlata:" autoComplete="email" placeholder="Your email address" type="email" required="" aria-invalid="false" class="css-rbiwe3" name="email" value=""/></div><style data-emotion="css 1hxvbez">.css-1hxvbez{font-family:"FeatureFlatText-Regular";font-size:1rem;line-height:120%;letter-spacing:0.02em;padding:4px;min-width:136px;z-index:1;position:absolute;right:0;opacity:0;bottom:25%;-webkit-transition:all 0.3s;transition:all 0.3s;}</style><div id="feedback-newsletter-sign-up-:R7elrnnnlata:" aria-hidden="true" class="css-1hxvbez"></div></div><style data-emotion="css huux4w">.css-huux4w{border-top:1px dashed #1f1d1a;height:1px;width:100%;margin-top:10px;}</style><div class="css-huux4w"></div><style data-emotion="css qame98">.css-qame98{padding:18px 10px 20px;color:#fcfae4;background-color:#1f1d1a;font-size:1.25rem;line-height:120%;margin:0;font-variation-settings:"wght" 495;font-weight:395;font-family:"FeatureFlatText-Bold",serif;margin-top:10px;border:0;width:100%;}.css-qame98:not(:disabled){cursor:pointer;}</style><button data-testid="barrier-sign-up-button" type="submit" class="css-qame98">SignÂ up forÂ free</button><style data-emotion="css rfogjk">.css-rfogjk{width:100%;-webkit-text-decoration:none;text-decoration:none;padding:18px 10px 20px;color:#1f1d1a;border:1px solid #1f1d1a;background-color:#f8f5d7;font-size:1.25rem;line-height:120%;margin:0;font-variation-settings:"wght" 495;font-weight:395;font-family:"FeatureFlatText-Bold",serif;margin-top:10px;}.css-rfogjk:not(:disabled){cursor:pointer;}</style><button data-testid="barrier-sign-in-button" type="submit" class="css-rfogjk">SignÂ in</button><style data-emotion="css yp48zo">.css-yp48zo{color:#53524c;font-family:"Helvetica";font-size:0.875rem;margin-top:10px;text-align:center;}</style><div class="css-yp48zo">Already subscribed? Sign in and we wonât show you this message again.</div><style data-emotion="css z28g56">.css-z28g56{border:0;background-color:inherit;padding:30px 15px;width:100%;font-family:"FeatureFlatHeadline",serif;font-weight:395;font-variation-settings:"wght" 495,"opsz" 10;font-size:1rem;color:#1f1d1a;line-height:120%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:center;-ms-flex-pack:center;-webkit-justify-content:center;justify-content:center;gap:10px;cursor:pointer;}</style><button type="button" class="css-z28g56">Take me back to the article <svg width="16" height="20" viewBox="0 0 16 20" fill="none" xmlns="http://www.w3.org/2000/svg" style="width:16px;height:20px"><path d="M5 15.1734C5.54701 15.4624 6.02564 15.7418 6.4359 16.0116C6.84615 16.3006 7.18803 16.58 7.46154 16.8497L7.46154 -7.73355e-07L8.53846 -5.37986e-07L8.53846 16.8497C8.82906 16.58 9.17948 16.3006 9.58974 16.0116C10 15.7418 10.4701 15.4624 11 15.1734L11 16.185C9.75213 17.3988 8.82906 18.6705 8.23077 20L7.76923 20C7.18803 18.6705 6.26496 17.3988 5 16.185L5 15.1734Z" fill="#53524C"></path></svg></button></form></div><script src="https://static.semafor.com/_next/static/chunks/webpack-d1bfd1d798fde2bf.js" async=""></script><script>(self.__next_f=self.__next_f||[]).push([0]);self.__next_f.push([2,null])</script><script>self.__next_f.push([1,"1:HL[\"https://static.semafor.com/_next/static/css/5e0bc50507719ef8.css\",\"style\"]\n0:\"$L2\"\n"])</script><script>self.__next_f.push([1,"3:HL[\"https://static.semafor.com/_next/static/css/6f8c5c77224cbaea.css\",\"style\"]\n4:HL[\"https://static.semafor.com/_next/static/css/0f210b31207e2542.css\",\"style\"]\n"])</script><script>self.__next_f.push([1,"5:I[47690,[],\"\"]\n8:I[5613,[],\"\"]\na:I[31778,[],\"\"]\nd:I[48955,[],\"\"]\n9:[\"slug\",\"05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines\",\"c\"]\n"])</script><script>self.__next_f.push([1,"2:[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"https://static.semafor.com/_next/static/css/5e0bc50507719ef8.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\"}]],[\"$\",\"$L5\",null,{\"buildId\":\"j9NrYrgq20Kj0rcpLKQM-\",\"assetPrefix\":\"https://static.semafor.com\",\"initialCanonicalUrl\":\"/article/05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines\",\"initialTree\":[\"\",{\"children\":[\"article\",{\"children\":[[\"slug\",\"05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines\",\"c\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],\"initialSeedData\":[\"\",{\"children\":[\"article\",{\"children\":[[\"slug\",\"05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines\",\"c\"],{\"children\":[\"__PAGE__\",{},[\"$L6\",\"$L7\",null]]},[\"$\",\"$L8\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\",\"article\",\"children\",\"$9\",\"children\"],\"loading\":\"$undefined\",\"loadingStyles\":\"$undefined\",\"loadingScripts\":\"$undefined\",\"hasLoading\":false,\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$La\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"notFoundStyles\":\"$undefined\",\"styles\":[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"https://static.semafor.com/_next/static/css/6f8c5c77224cbaea.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"https://static.semafor.com/_next/static/css/0f210b31207e2542.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\"}]]}]]},[\"$\",\"$L8\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\",\"article\",\"children\"],\"loading\":\"$undefined\",\"loadingStyles\":\"$undefined\",\"loadingScripts\":\"$undefined\",\"hasLoading\":false,\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$La\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"notFoundStyles\":\"$undefined\",\"styles\":null}]]},[null,\"$Lb\",null]],\"initialHead\":[false,\"$Lc\"],\"globalErrorComponent\":\"$d\"}]]\n"])</script><script>self.__next_f.push([1,"e:I[17218,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"185\",\"static/chunks/app/layout-72863275accc636e.js\"],\"TermlyEmbed\"]\nf:I[92436,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"185\",\"static/chunks/app/layout-72863275accc636e.js\"],\"MoatSignalScript\"]\n10:I[92436,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"185\",\"static/chunks/app/layout-72863275accc636e.js\"],\"Gtag"])</script><script>self.__next_f.push([1,"ConfigScript\"]\n11:I[92436,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"185\",\"static/chunks/app/layout-72863275accc636e.js\"],\"PushlyScript\"]\n12:I[92436,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"185\",\"static/chunks/app/layout-72863275accc636e.js\"],\"SnowPlowScript\"]\n13:I[92436,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"185\",\"static/chunks/app/layout-72863275acc"])</script><script>self.__next_f.push([1,"c636e.js\"],\"LiveRampPixel\"]\n14:I[92436,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"185\",\"static/chunks/app/layout-72863275accc636e.js\"],\"LiveRampATSPixel\"]\n15:I[85935,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"185\",\"static/chunks/app/layout-72863275accc636e.js\"],\"\"]\n16:I[50875,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df7"])</script><script>self.__next_f.push([1,"3.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/article/%5B...slug%5D/page-13b775446028798a.js\"],\"SemaWelcomeLog\"]\n17:I[62285,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/article/%5B...slug%5D/page-13b775446028798a.js\"],\"ConsentProvider\"]\n18:I[62285,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/"])</script><script>self.__next_f.push([1,"626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/article/%5B...slug%5D/page-13b775446028798a.js\"],\"ConsentScripts\"]\n19:I[95888,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/article/%5B...slug%5D/page-13b775446028798a.js\"],\"FeatureProvider\"]\n1a:I[42099,[\"9"])</script><script>self.__next_f.push([1,"07\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/article/%5B...slug%5D/page-13b775446028798a.js\"],\"SemaforSessionProvider\"]\n1b:I[98223,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/article/%"])</script><script>self.__next_f.push([1,"5B...slug%5D/page-13b775446028798a.js\"],\"AdManagerProvider\"]\n1c:I[26626,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"185\",\"static/chunks/app/layout-72863275accc636e.js\"],\"StickyProvider\"]\n1d:I[80449,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"601\",\"static/chunks/app/error-1777214bcca54bb2.js\"],\"\"]\n1e:I[81749,[\"907\",\"sta"])</script><script>self.__next_f.push([1,"tic/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/article/%5B...slug%5D/page-13b775446028798a.js\"],\"Image\"]\n"])</script><script>self.__next_f.push([1,"b:[\"$\",\"html\",null,{\"lang\":\"en\",\"children\":[[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/site.webmanifest\",\"crossOrigin\":\"use-credentials\"}],[\"$\",\"$Le\",null,{}],[\"$\",\"$Lf\",null,{}],[\"$\",\"$L10\",null,{\"category\":\"analytics\"}],[\"$\",\"$L10\",null,{\"category\":\"advertising\"}],[\"$\",\"$L11\",null,{}],[\"$\",\"$L12\",null,{}],[\"$\",\"$L13\",null,{}],[\"$\",\"$L14\",null,{}],[\"$\",\"$L15\",null,{\"id\":\"build-info\",\"strategy\":\"afterInteractive\",\"type\":\"application/json\",\"dangerouslySetInnerHTML\":{\"__html\":\"{\\\"rendered\\\":\\\"Thu May 23 2024 18:17:46 GMT+0000 (Coordinated Universal Time)\\\",\\\"rendered_timestamp\\\":1716488266704,\\\"hash\\\":\\\"cd81cb6a165004109ae919f084c0176e4fe0c11b\\\",\\\"branch\\\":\\\"main\\\"}\"}}],[\"$\",\"body\",null,{\"style\":{\"overflowX\":\"hidden\"},\"children\":[[\"$\",\"$L16\",null,{}],[\"$\",\"$L17\",null,{\"children\":[[\"$\",\"$L18\",null,{}],[\"$\",\"$L19\",null,{\"featuresFromHeaders\":[],\"lazyFeaturesApi\":true,\"children\":[\"$\",\"$L1a\",null,{\"children\":[\"$\",\"$L1b\",null,{\"children\":[\"$\",\"$L1c\",null,{\"children\":[\"$\",\"$L8\",null,{\"parallelRouterKey\":\"children\",\"segmentPath\":[\"children\"],\"loading\":\"$undefined\",\"loadingStyles\":\"$undefined\",\"loadingScripts\":\"$undefined\",\"hasLoading\":false,\"error\":\"$1d\",\"errorStyles\":[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"https://static.semafor.com/_next/static/css/6f8c5c77224cbaea.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\"}]],\"errorScripts\":[],\"template\":[\"$\",\"$La\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[\"$\",\"main\",null,{\"style\":{\"display\":\"flex\",\"flexDirection\":\"column\",\"justifyContent\":\"center\",\"alignItems\":\"center\",\"minHeight\":\"100vh\"},\"children\":[[\"$\",\"div\",null,{\"style\":{\"marginBottom\":\"40px\",\"textTransform\":\"uppercase\",\"fontFamily\":\"Courier\",\"fontSize\":\"1.375rem\",\"textAlign\":\"center\"},\"children\":[\"$\",\"p\",null,{\"children\":\"Error: 404 Page not found\"}]}],[\"$\",\"section\",null,{\"children\":[\"$\",\"a\",null,{\"style\":{\"display\":\"block\",\"width\":\"100%\",\"maxWidth\":\"612px\"},\"href\":\"/\",\"children\":[\"$\",\"$L1e\",null,{\"style\":{\"width\":\"100%\",\"objectFit\":\"contain\"},\"src\":\"https://static.semafor.com/_next/static/media/Sema404.55ac3b60.png\",\"alt\":\"Sema 4 oh 4, Home\",\"width\":612,\"height\":259,\"unoptimized\":true}]}]}]]}],\"notFoundStyles\":[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"https://static.semafor.com/_next/static/css/6f8c5c77224cbaea.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"https://static.semafor.com/_next/static/css/0f210b31207e2542.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\"}]],\"styles\":null}]}]}]}]}]]}]]}]]}]\n"])</script><script>self.__next_f.push([1,"20:I[91842,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/article/%5B...slug%5D/page-13b775446028798a.js\"],\"UserProvider\"]\n21:I[62285,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/artic"])</script><script>self.__next_f.push([1,"le/%5B...slug%5D/page-13b775446028798a.js\"],\"ConsentAnalytics\"]\n22:I[58524,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/article/%5B...slug%5D/page-13b775446028798a.js\"],\"ThemeProvider\"]\n23:I[58524,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"stat"])</script><script>self.__next_f.push([1,"ic/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/article/%5B...slug%5D/page-13b775446028798a.js\"],\"THEME_DEFAULT\"]\n24:I[5941,[\"907\",\"static/chunks/907-8c629f6d0cffc20a.js\",\"626\",\"static/chunks/626-bdaa8c7a3f769519.js\",\"462\",\"static/chunks/462-25b4f5a6f256df73.js\",\"896\",\"static/chunks/896-ca0468535763e9e5.js\",\"226\",\"static/chunks/app/article/%5B...slug%5D/page-13b775446028798a.js\"],\"DefaultArticle\"]\n1f:T424,"])</script><script>self.__next_f.push([1,"{\"@context\":\"https://schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"South Africaâs Afrigen targets local diseases with mRNA vaccines | Semafor\",\"url\":\"https://www.semafor.com/article/05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines\",\"thumbnailUrl\":\"https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=256,0,1089,1089\u0026w=800\u0026h=800\u0026q=75\u0026auto=format\",\"image\":[\"https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=256,0,1089,1089\u0026w=600\u0026h=600\u0026q=75\u0026auto=format\",\"https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=74,0,1452,1089\u0026w=800\u0026h=600\u0026q=75\u0026auto=format\",\"https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=0,95,1600,900\u0026w=800\u0026h=450\u0026q=75\u0026auto=format\"],\"datePublished\":\"2024-05-23T10:16:24Z\",\"dateModified\":\"2024-05-23T14:37:01+01:00\",\"articleSection\":\"africa\",\"creator\":[\"Alexis Akwagyiram\"],\"author\":[{\"@type\":\"Person\",\"name\":\"Alexis Akwagyiram\",\"url\":\"https://www.semafor.com/author/alexis-akwagyiram\"}]}"])</script><script>self.__next_f.push([1,"7:[[\"$\",\"link\",null,{\"rel\":\"canonical\",\"href\":\"https://www.semafor.com/article/05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines\"}],[\"$\",\"script\",null,{\"type\":\"application/ld+json\",\"dangerouslySetInnerHTML\":{\"__html\":\"$1f\"}}],[\"$\",\"$L20\",null,{\"softCookie\":true,\"children\":[\"$\",\"$L1b\",null,{\"docID\":\"e7c98144-9897-42a3-9312-b8c3aa7016ba\",\"children\":[[\"$\",\"$L21\",null,{}],[\"$\",\"script\",null,{\"id\":\"breadcrumbs\",\"type\":\"application/ld+json\",\"dangerouslySetInnerHTML\":{\"__html\":\"{\\\"@context\\\":\\\"https://schema.org\\\",\\\"@type\\\":\\\"BreadcrumbList\\\",\\\"itemListElement\\\":[{\\\"@context\\\":\\\"http://schema.org\\\",\\\"@type\\\":\\\"ListItem\\\",\\\"name\\\":\\\"Africa\\\",\\\"position\\\":1,\\\"item\\\":\\\"https://www.semafor.com/vertical/africa\\\"}]}\"}}],[\"$\",\"$L22\",null,{\"theme\":\"$23\",\"children\":[\"$\",\"$L24\",null,{\"article\":{\"verticalDisplay\":[{\"label\":\"Africa\",\"_key\":\"africa\",\"value\":\"africa\"}],\"signal\":null,\"location\":null,\"ledeVideo\":null,\"publishedTimestamp\":\"2024-05-23T13:37:01+00:00\",\"_createdAt\":\"2024-05-23T10:16:24Z\",\"audioPlayer\":null,\"tragedy\":null,\"seoDescription\":\"South Africaâs Afrigen targets local diseases with mRNA vaccines\",\"ledePhoto\":{\"attribution\":\"Nicky Lloyd/Getty Images\",\"asset\":{\"_ref\":\"image-c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089-jpg\",\"_type\":\"reference\"},\"imageEmbedExternalLink\":null,\"imageEmbedInternalLink\":null,\"schemaVersion\":1,\"_type\":\"image\"},\"updatedTimestamp\":\"2024-05-23T14:37:01+01:00\",\"authors\":[{\"headshot\":\"https://cdn.sanity.io/images/ifn0l6bs/production/a00cce649638d4c47c94beeec22ea4c01c2e29d8-1504x1600.jpg\",\"name\":\"Alexis Akwagyiram\",\"authorSlug\":\"/author/alexis-akwagyiram\"}],\"headline\":\"South Africaâs Afrigen targets local diseases with mRNA vaccines\",\"slug\":\"/article/05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines\",\"description\":[{\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"South African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist's team to develop gene therapy treatments that target diseases that plague Africa. \",\"_key\":\"7e6d2f2440fb0\"}],\"_type\":\"block\",\"style\":\"normal\",\"_key\":\"5e2c5b9ea42e\"}],\"intro\":{\"schemaVersion\":1,\"_type\":\"intro\",\"body\":null},\"vertical\":\"africa\",\"semaforms\":[{\"schemaVersion\":1,\"scoop\":[{\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"KIGALI, Rwanda â South African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist to develop groundbreaking gene therapy treatments that target diseases that have plagued Africa for decades.\",\"_key\":\"1cfdd4e903640\"}],\"_type\":\"block\",\"style\":\"normal\",\"_key\":\"ee7be1342244\",\"markDefs\":[]},{\"style\":\"normal\",\"_key\":\"1e722a3712f1\",\"markDefs\":[],\"children\":[{\"marks\":[],\"text\":\"The Cape Town-based company is working with the University of Pennsylvania's Drew Weissman, who won a Nobel Prize for developing mRNA vaccines used to fight COVID-19.\",\"_key\":\"0631e48367af0\",\"_type\":\"span\"}],\"_type\":\"block\"},{\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"âMy people are in his labs working with some of his top scientists on mRNA. And, of course, we are extremely interested to further collaborate,â Afrigen CEO Petro Terblanche told Semafor Africa. She said the company is exploring âopportunities to bring gene therapy to Africaâ through its ties with scientists at University of Pennsylvania.\",\"_key\":\"0f03b12676f50\"}],\"_type\":\"block\",\"style\":\"normal\",\"_key\":\"ac0990579600\"},{\"_key\":\"ad-block-1\",\"_type\":\"ad\",\"authorSlug\":\"/author/alexis-akwagyiram\",\"vertical\":[\"africa\"],\"count\":1,\"tragedy\":null,\"schemaVersion\":\"1\"},{\"_key\":\"d2a904a0c9a7\",\"markDefs\":[],\"children\":[{\"_key\":\"7cbbb6d3a8100\",\"_type\":\"span\",\"marks\":[],\"text\":\"Gene therapy refers to forms of treatment that add a new gene or repair a mutated one inside the human body.\"}],\"_type\":\"block\",\"style\":\"normal\"},{\"_key\":\"2c6129207310\",\"markDefs\":[{\"_type\":\"link\",\"href\":\"https://www.semafor.com/newsletter/12/21/2023/ghana-detty-december-tourists-revenue?utm_source=nowshare\u0026utm_medium=africa\u0026utm_campaign=Briefing#e\",\"_key\":\"09e62a3d8ce3\"},{\"href\":\"https://hms.harvard.edu/news/gene-editing-improves-vision-some-people-inherited-blindness\",\"_key\":\"9c653d75af81\",\"_type\":\"link\"},{\"_type\":\"link\",\"href\":\"https://www.npr.org/sections/health-shots/2024/01/24/1226595039/gene-therapy-shows-promise-for-an-inherited-form-of-deafness\",\"_key\":\"a3fd78dcd18d\"}],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"Treatments for \",\"_key\":\"e9c7402fe6ca0\"},{\"_type\":\"span\",\"marks\":[\"09e62a3d8ce3\"],\"text\":\"sickle cell disease\",\"_key\":\"e9c7402fe6ca1\"},{\"_type\":\"span\",\"marks\":[],\"text\":\", a condition that mostly afflicts people of African descent, have been approved by US authorities in recent months. Gene therapy treatments are also being developed to treat \",\"_key\":\"e9c7402fe6ca2\"},{\"text\":\"blindness\",\"_key\":\"e9c7402fe6ca3\",\"_type\":\"span\",\"marks\":[\"9c653d75af81\"]},{\"_type\":\"span\",\"marks\":[],\"text\":\" and \",\"_key\":\"e9c7402fe6ca4\"},{\"text\":\"deafness\",\"_key\":\"e9c7402fe6ca5\",\"_type\":\"span\",\"marks\":[\"a3fd78dcd18d\"]},{\"_type\":\"span\",\"marks\":[],\"text\":\".\",\"_key\":\"e9c7402fe6ca6\"}],\"_type\":\"block\",\"style\":\"normal\"}],\"_type\":\"scoop\",\"_key\":\"1ef2504b7caf\",\"title\":\"The Scoop\"},{\"knowMore\":[{\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"Afrigenâs model involves developing the technology and expertise to create vaccines and therapeutic drugs which it then shares with partner manufacturers. It has a mandate to share technology and expertise with vaccine producers and research institutions under an initiative backed by the World Health Organization.\",\"_key\":\"a10715a9660d0\"}],\"_type\":\"block\",\"style\":\"normal\",\"_key\":\"b5d3933ee58c\",\"markDefs\":[]},{\"_key\":\"ad-block-2\",\"_type\":\"ad\",\"authorSlug\":\"/author/alexis-akwagyiram\",\"vertical\":[\"africa\"],\"count\":2,\"tragedy\":null,\"schemaVersion\":\"1\"},{\"style\":\"normal\",\"_key\":\"e5862923ed66\",\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"Terblanche, speaking to Semafor Africa on the sidelines of the Africa CEO Forum in Kigali, said the company shared information with 15 partners â made up of vaccine manufacturers and research institutions â in South Africa, Senegal, Nigeria, Kenya, Tunisia, and Egypt.\",\"_key\":\"6fd2a08e89cc0\"}],\"_type\":\"block\"},{\"style\":\"normal\",\"_key\":\"f4c395f481c3\",\"markDefs\":[],\"children\":[{\"text\":\"She said Afrigen is developing a new generation of mRNA vaccines for a range of diseases including HIV, tuberculosis (TB), Rift Valley fever, and gonorrhea.\",\"_key\":\"98faaff42efb0\",\"_type\":\"span\",\"marks\":[]}],\"_type\":\"block\"},{\"_key\":\"c74e7f3bf44f\",\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"Afrigen needs âa pipeline of productsâ that can be produced on an mRNA platform, Terblanche told Semafor Africa. âAs we move these through the pipeline we will continue to focus on diseases which are a priority for the region,â she said.\",\"_key\":\"3fa9f203fd5f0\"}],\"_type\":\"block\",\"style\":\"normal\"},{\"_key\":\"ad-block-3\",\"_type\":\"ad\",\"authorSlug\":\"/author/alexis-akwagyiram\",\"vertical\":[\"africa\"],\"count\":3,\"tragedy\":null,\"schemaVersion\":\"1\"},{\"_key\":\"6d1171e94bd0\",\"markDefs\":[{\"_key\":\"b627619faa4d\",\"_type\":\"link\",\"href\":\"https://www.forbes.com/sites/juergeneckhardt/2023/11/16/nobel-winner-drew-weissman-shares-7-insights-on-future-mrna-breakthroughs/\"}],\"children\":[{\"_key\":\"1fe53b5b5b6c0\",\"_type\":\"span\",\"marks\":[],\"text\":\"Vaccines based on messenger ribonucleic acid (mRNA) technology train the immune system to recognize and fight threats. Weissman, whose laboratory is developing gene therapy for sickle cell disease, has previously spoken of the potential to \"},{\"_type\":\"span\",\"marks\":[\"b627619faa4d\"],\"text\":\"harness mRNA technology\",\"_key\":\"1fe53b5b5b6c1\"},{\"text\":\" to produce relatively cheap vaccines and therapeutic treatments that can be rolled out in low and middle income countries.\",\"_key\":\"1fe53b5b5b6c2\",\"_type\":\"span\",\"marks\":[]}],\"_type\":\"block\",\"style\":\"normal\"}],\"_type\":\"knowMore\",\"_key\":\"9186c990b23e\",\"schemaVersion\":1},{\"author\":{\"twitter\":\"alexisak\",\"_createdAt\":\"2022-10-12T15:33:13Z\",\"_rev\":\"AG4a4HYRVYBamRPNPDEQOs\",\"headshot\":\"https://cdn.sanity.io/images/ifn0l6bs/production/a00cce649638d4c47c94beeec22ea4c01c2e29d8-1504x1600.jpg\",\"schemaVersion\":2,\"publishedTimestamp\":\"2023-03-26T23:00:42Z\",\"documentVersion\":\"1.0.1\",\"_type\":\"author\",\"_id\":\"df09cdb2-9fa8-4c25-bb3b-c7a8a744597b\",\"authorTitle\":\"Managing Editor, Africa\",\"authorSlug\":\"/author/alexis-akwagyiram\",\"email\":\"aakwagyiram@semafor.com\",\"_updatedAt\":\"2023-05-05T01:15:38Z\",\"shortName\":\"Alexis\",\"updatedTimestamp\":\"2023-03-26T23:00:42Z\",\"name\":\"Alexis Akwagyiram\",\"bio\":[{\"markDefs\":[],\"children\":[{\"text\":\"Alexis has covered African news and current affairs for more than a decade at the BBC, Reuters and Financial Times. He was a BBC Africa reporter and led a multimedia team as the Reuters bureau chief in Nigeria. Alexis shaped the FTâs pandemic coverage as its health and science editor.\",\"_key\":\"9ffc59d4d1730\",\"_type\":\"span\",\"marks\":[]}],\"_type\":\"block\",\"style\":\"normal\",\"_key\":\"88b3ef8c3b29\"}],\"newsletterAudience\":\"Africa\"},\"_type\":\"reportersTake\",\"_key\":\"1c31590f55c5\",\"thescoop\":[{\"_type\":\"block\",\"style\":\"normal\",\"_key\":\"57514b45da08\",\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"The COVID-19 pandemic taught us so much. The early scramble for vaccines was a stark glimpse of global power dynamics, as wealthy nations secured access to the first shots when the world teetered on the brink of uncertainty. But the pandemic also spurred incredible innovation.\",\"_key\":\"3198d7696a4f0\"}]},{\"_key\":\"bc67c12c233b\",\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"The takeaway from both lessons was the same: African countries need to manufacture more vaccines and drugs locally. Thatâs why the African Union has set a target of 60% of vaccines, therapeutics, and other medical products being manufactured locally by 2040. And international vaccine group Gavi in December approved a financing instrument that will make up to $1 billion available to support vaccine manufacturing in Africa.\",\"_key\":\"a999b15f22c70\"}],\"_type\":\"block\",\"style\":\"normal\"},{\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"In mRNA technology, the continent has an opportunity to harness an innovative form of treatment that, with time and investment, has the potential to lower the cost of healthcare. Thatâs because these treatments could offer protection against a broad range of diseases that have previously been ignored. Many conditions, from sickle cell to malaria and HIV, could one day be treated with as little as a single injection.\",\"_key\":\"be1ada8d44530\"}],\"_type\":\"block\",\"style\":\"normal\",\"_key\":\"0c18a20363f4\"},{\"_key\":\"33160ab2e198\",\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"Obviously, this is important on a human level because of the physical and mental anguish illnesses can cause for sufferers and their loved ones. We often talk about Africaâs relative youth, compared to other parts of the world. But itâs also important to ensure that future generations are healthy.\",\"_key\":\"598e1e1c6b920\"}],\"_type\":\"block\",\"style\":\"normal\"},{\"_type\":\"block\",\"style\":\"normal\",\"_key\":\"5020b036af0b\",\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"But none of this will be easy. The collaborations involving Afrigen are just the start of a process that could take years and would need the backing of governments and global health bodies. The potential impact can be realized, but African countries need to build their biotech sectors to make it happen.\",\"_key\":\"4c1da111adb60\"}]}],\"schemaVersion\":1},{\"schemaVersion\":1,\"_type\":\"roomForDisagreement\",\"_key\":\"b550fd97a7d0\",\"roomForDisagreement\":[{\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"At present, mRNA vaccines typically must be stored at very cold temperatures of minus 20 C to minus 80 C (minus 4 F to minus 112 F), which drives up the cost. The temperature requirements have been a barrier to entry in poorer countries which lack such refrigeration facilities.\",\"_key\":\"d25a9a6140b40\"}],\"_type\":\"block\",\"style\":\"normal\",\"_key\":\"a7b3310020eb\"},{\"_key\":\"9872d6b37802\",\"markDefs\":[],\"children\":[{\"marks\":[],\"text\":\"Terblanche said Afrigen and its partners had developed processes to ensure thermostability of products between 2 C and 8 C (35.6 F and 46.4 F). âWeâre working with partners to innovate around the current mRNA vaccine because that also reduces the cost,â she said.\",\"_key\":\"1a1a2cce4f010\",\"_type\":\"span\"}],\"_type\":\"block\",\"style\":\"normal\"}]},{\"where\":\"Central African Republic\",\"_key\":\"c19efb31788c\",\"theViewFrom\":[{\"style\":\"normal\",\"_key\":\"eaa796430d0d\",\"markDefs\":[],\"children\":[{\"_key\":\"220a005737a10\",\"_type\":\"span\",\"marks\":[],\"text\":\"Forms of gene therapy âcould revolutionize medical care in Africaâ by enabling patients to receive cures âin countries that still need time to develop comprehensive healthcare systems, said Yap Boum II, executive director of the Institut Pasteur de Bangui.\"}],\"_type\":\"block\"},{\"_key\":\"ba404af5259a\",\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"He said investment in training programs to develop local expertise in mRNA technology would be âessentialâ for it to be taken up, adding that âharmonizing and simplifying regulatory frameworks across the continentâ would expedite the approval and implementation of new technologies.\",\"_key\":\"fd88df7a23990\"}],\"_type\":\"block\",\"style\":\"normal\"},{\"markDefs\":[],\"children\":[{\"_type\":\"span\",\"marks\":[],\"text\":\"Boum told Semafor Africa the widespread deployment of techniques like mRNA technology âwill take yearsâ because it would only follow the building of human capacity and the sharing of technology, which would require investment.\",\"_key\":\"1eadb44656b60\"}],\"_type\":\"block\",\"style\":\"normal\",\"_key\":\"87281b869f74\"}],\"schemaVersion\":1,\"_type\":\"theViewFrom\"},{\"schemaVersion\":1,\"_type\":\"furtherReading\",\"_key\":\"a5d2ce3b2125\",\"furtherReading\":[{\"listItem\":\"bullet\",\"markDefs\":[{\"_key\":\"d0847a2a2b45\",\"_type\":\"link\",\"href\":\"https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-puts-kenya-plant-plans-hold-covid-vaccine-demand-slumps-2024-04-11/\"},{\"_type\":\"link\",\"href\":\"https://africacdc.org/news-item/africa-cdcs-statement-on-modernas-plan-to-reassess-commitment-to-african-vaccine-manufacturing/\",\"_key\":\"1a4a98170262\"}],\"children\":[{\"_type\":\"span\",\"marks\":[\"strong\"],\"text\":\"Moderna\",\"_key\":\"b2dc213450f90\"},{\"_type\":\"span\",\"marks\":[],\"text\":\" \",\"_key\":\"b2dc213450f91\"},{\"_type\":\"span\",\"marks\":[\"strong\"],\"text\":\"last month said it had put on hold\",\"_key\":\"b2dc213450f92\"},{\"_type\":\"span\",\"marks\":[],\"text\":\" plans to build a mRNA vaccine \",\"_key\":\"b2dc213450f93\"},{\"text\":\"manufacturing plant\",\"_key\":\"b2dc213450f94\",\"_type\":\"span\",\"marks\":[\"d0847a2a2b45\"]},{\"_key\":\"b2dc213450f95\",\"_type\":\"span\",\"marks\":[],\"text\":\" in Kenya. The Africa Centres for Disease Control and Prevention accused the US biotech company of \"},{\"marks\":[\"1a4a98170262\"],\"text\":\"âabandoningâ its commitment\",\"_key\":\"b2dc213450f96\",\"_type\":\"span\"},{\"marks\":[],\"text\":\" to vaccine equity.\",\"_key\":\"b2dc213450f97\",\"_type\":\"span\"}],\"level\":1,\"_type\":\"block\",\"style\":\"normal\",\"_key\":\"b40426e10e70\"}]}],\"_id\":\"e7c98144-9897-42a3-9312-b8c3aa7016ba\",\"sematexts\":null,\"lastPublishedFormattedDate\":\"May 23, 2024, 9:37am EDT\",\"articleType\":\"standard\"},\"forceShowLedePhoto\":false,\"error\":null}]}]]}]}]]\n"])</script><script>self.__next_f.push([1,"c:[[\"$\",\"meta\",\"0\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1\"}],[\"$\",\"meta\",\"1\",{\"charSet\":\"utf-8\"}],[\"$\",\"title\",\"2\",{\"children\":\"South Africaâs Afrigen targets local diseases with mRNA vaccines | Semafor\"}],[\"$\",\"meta\",\"3\",{\"name\":\"description\",\"content\":\"South African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist's team to develop gene therapy treatments that target diseases that plague Africa. \"}],[\"$\",\"meta\",\"4\",{\"name\":\"robots\",\"content\":\"max-image-preview:large\"}],[\"$\",\"meta\",\"5\",{\"name\":\"article:published_time\",\"content\":\"2024-05-23T13:37:01+00:00\"}],[\"$\",\"meta\",\"6\",{\"name\":\"article:modified_time\",\"content\":\"2024-05-23T14:37:01+01:00\"}],[\"$\",\"meta\",\"7\",{\"name\":\"article:section\",\"content\":\"africa\"}],[\"$\",\"meta\",\"8\",{\"name\":\"article:author\",\"content\":\"https://www.semafor.com/author/alexis-akwagyiram\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:title\",\"content\":\"South Africaâs Afrigen targets local diseases with mRNA vaccines | Semafor\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:description\",\"content\":\"South African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist's team to develop gene therapy treatments that target diseases that plague Africa. \"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:url\",\"content\":\"https://www.semafor.com/article/05/23/2024/south-africas-afrigen-targets-local-diseases-with-mrna-vaccines\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:image\",\"content\":\"https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=0,125,1600,840\u0026w=1200\u0026h=630\u0026q=75\u0026auto=format\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image:height\",\"content\":\"1200\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:width\",\"content\":\"630\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"16\",{\"name\":\"twitter:card\",\"content\":\"summary_large_image\"}],[\"$\",\"meta\",\"17\",{\"name\":\"twitter:title\",\"content\":\"South Africaâs Afrigen targets local diseases with mRNA vaccines\"}],[\"$\",\"meta\",\"18\",{\"name\":\"twitter:description\",\"content\":\"South African biotech company Afrigen is collaborating with a Nobel Prize-winning scientist's team to develop gene therapy treatments that target diseases that plague Africa. \"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:image\",\"content\":\"https://img.semafor.com/c5dcf6986234cf84a84ba1b7cf0e401ae4d45735-1600x1089.jpg?rect=0,125,1600,840\u0026w=1200\u0026h=630\u0026q=75\u0026auto=format\"}],[\"$\",\"link\",\"20\",{\"rel\":\"apple-touch-icon\",\"href\":\"/apple-touch-icon.png\",\"sizes\":\"180x180\"}],[\"$\",\"link\",\"21\",{\"rel\":\"icon\",\"href\":\"/favicon-32x32.png\",\"type\":\"image/png\",\"sizes\":\"32x32\"}],[\"$\",\"link\",\"22\",{\"rel\":\"icon\",\"href\":\"/favicon-16x16.png\",\"type\":\"image/png\",\"sizes\":\"16x16\"}],[\"$\",\"link\",\"23\",{\"rel\":\"mask-icon\",\"href\":\"/safari-pinned-tab-icon.svg\",\"type\":\"image/png\",\"sizes\":\"16x16\",\"color\":\"#000000\"}]]\n"])</script><script>self.__next_f.push([1,"6:null\n"])</script><script>self.__next_f.push([1,""])</script></body></html>